Juno Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Juno Therapeutics, Inc.
CIK #0001594864
EDGAR Form CIK 2011 - 2025
10-K [0001594864]
10-Q [0001594864]
3 [0001594864]
4 [0001594864]
8-K [0001594864]
D [0001594864]
SC 13D [0001594864]
SC 13G [0001594864]
Form 13D/13G Filer Form 13D/13G Subject Filed
Capital International Investors Juno Therapeutics Inc [2018-02-14]
Vanguard Group Inc Juno Therapeutics Inc [2017-02-10]
Baillie Gifford & Co Juno Therapeutics Inc [2016-04-07]
Celgene Rivot Ltd Juno Therapeutics Inc [2015-07-08]
FMR LLC Juno Therapeutics Inc [2015-02-13]
Arch Venture Fund VII LP Juno Therapeutics Inc [2015-02-11]
Bratton Douglas K Juno Therapeutics Inc [2014-12-29]
Form 3/4/5 Subject 2011 - 2025
Juno Therapeutics, Inc.
Wilderotter Mary Agnes
Pien Howard H
Nelsen Robert
Evnin Anthony B
Daniel Thomas O
Cassidy Bernard J
Bishop Hans Edgar
Barron Hal
Azelby Robert
Agarwal Sunil
Lee Ann L
Klausner Richard
Harr Steve
Flatley Jay T
Blue Magpie Corp
Celgene Switzerland LLC
Celgene Corp /DE/
CL Alaska, L.P.
Bratton Douglas K
Crestline SI (GP), L.P.
Crestline Investors, Inc.
Crestline Management, LP
Vessey Rupert
Levitsky Hyam
Tessier-Lavigne Marc
ARCH Venture Partners VII, LLC
Crandell Keith
ARCH Venture Fund VII, L.P.
ARCH Venture Partners VII, L.P.
Bybee Clinton
Frohlich Mark W
Terms | Privacy | Guide
tony@aum13f.com